Skip to main content
Industry News
Ozanimod shows promise in treating Crohn's

A study led by Dr. Brian Feagan of the University of Western Ontario found that patients with Crohn's disease who were treated with ozanimod experienced a reduction in Crohn's Disease Activity Index, and some went into clinical remission. Researchers noted adverse events, including Crohn's flares, according to the study, which was published in The Lancet Gastroenterology & Hepatology.

Full Story: